We are pleased to welcome Prof. Rui Miguel Pinheiro Vitorino on board as the new Editor-in-Chief of Innovative Medicines & Omics. Dr. Rui Vitorino works in the Department of Medical Sciences at the University of Aveiro, where he is the principal investigator. His expertise in OMICS, especially in proteomics and bioinformatics, makes him a pioneer in this field. Dr. Vitorino's research focuses on the detailed analysis of biofluids, such as saliva and urine, to decipher molecular pathways associated with different disease phenotypes. He employs a variety of multidisciplinary techniques for protein enrichment and biofluid analysis, all aimed at improving the detection and understanding of disease biomarkers. Dr. Vitorino’s academic track record is marked by over 240 publications. He is involved in over 40 scientific projects, many of which are supported by the European Union and involve international collaborations. Dr. Vitorino is known for his expertise in the field of proteomics. He has collaborated with various research groups worldwide and has been instrumental in major projects such as the EU-ETN and COST Actions. His work is a testament not only to his deep knowledge of the field, but also to his commitment to promoting scientific understanding and collaboration. We warmly welcome Prof. Rui Miguel Pinheiro Vitorino in his new role as Editor-in-Chief, and we look forward to his leading Innovative Medicines & Omics to many more milestones.  

Innovative Medicines & Omics (IMO) is a peer-reviewed and open-access journal that publishes articles on the critical analysis of human health and animal medicine-related original omics research and its applications in innovative medicines.  The journal includes a variety of omics layers, such as genomics, proteomics, epigenomics metabolomics, lipidomics, peptidomics, metagenomics, microbiome, pharmacogenomics, toxicogenomics, etc., with the focus on disease etiology, prevention, treatment, prognosis and monitoring. Features include original research articles, reviews, case reports, short communications and editorials. Topics of particular interest include, but are not limited to: Disease evolution and heterogeneity Single-cell sequencing technique Circulating tumor cell Personalized medicine Drug sensitivity screening Combination therapy Drug resistance Disease therapeutic mechanism and marker detection Database and web server Computational method Assisted reproduction Embryonic development Animal organ regeneration Bioproduct and biomaterial Novel therapeutic strategies High-throughput screening Therapeutic targets Combinatorial chemistry, parallel synthesis and library design Drug delivery Advances in key compound classes and therapeutic areas Automation and technology Editor-in-Chief Prof. Enrico Mini Emeritus Professor of Medical Oncology,Department of Health Sciences, University of Florence, Florence, Italy   Prof. Changyuan YU College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China We welcome researchers and scholars in the related fields to submit manuscripts to IMO. IMO upholds high publishing standards and adheres to rigorous peer review prior to acceptance. Potential authors are encouraged to make submissions through online submission system： http://journals.accscience.com/index.php/IMO/login If you have any question about submissions and publications, please contact the Editorial Office at imo.office@accscience.sg.  Warm Regards,Editorial OfficeInnovative Medicines & Omics  AccScience Publishing

Innovative Medicines & Omics [IMO] publishes rigorously peer-reviewed and high-quality original research articles and authoritative reviews that focus on pharmacy and omics in the field of animal and human health.  Now we are currently looking for 1-2 Associate Editors for our journal. This is an opportunity to exchange with and learn from experts in the same field. IMO is an international, double-blind peer-reviewed, quick-refereeing open-access journal. The journal was launched in April, 2023 by cooperating with Beijing University of Chemical Technology by Singapore AccScience Publishing (ASP, https://accscience.com/).  We have already established a very good Editorial Board: https://accscience.com/journal/IMO/about/editorial_board We encourage applications from researchers with a background in a range of subject areas (https://accscience.com/journal/IMO/about/aims_scope).Should you decide to serve on this position, you would be responsible for some of the following tasks depending on your availability: - Assisting the Editor-in-Chief in journal management;- Inviting additional scientists to join the Editorial Board;- Recommending timely topics and suggesting potential guest editors;- Publishing one paper per year, free of charge, in open access;- Promoting the journal. As we provide a low-cost publishing service in open access format, we unfortunately cannot additionally pay an honorarium. The term of the Associate Editor membership is three years and could then be renewed. We believe that your expertise together with our rigorous editorial policies can build a high-standard journal specifically dedicated to Pharmacy and Omics research. If you are interested in becoming an Associate Editor for IMO, please send your full academic CV and a short cover letter that details your interest and enthusiasm for the position to imo.office@accscience.sg <imo.office@accscience.sg>. Welcome to join us! Innovative Medicines & Omics Editorial Office

Innovative Medicines & Omics [IMO] publishes rigorously peer-reviewed and high-quality original research articles and authoritative reviews that focus on pharmacy and omics in the field of animal and human health.  Now we are currently looking for Editorial Board Members for our journal. This is an opportunity to exchange with and learn from experts in the same field. As you may know, IMO is an international, double-blind peer-reviewed, quick-refereeing open-access journal. The journal was launched in April, 2023 by cooperating with Beijing University of Chemical Technology by Singapore AccScience Publishing (ASP, https://accscience.com/). We have already established a very good Editorial Board:https://accscience.com/journal/IMO/about/editorial_board  We encourage applications from researchers with a background in a range of subject areas (https://accscience.com/journal/IMO/about/aims_scope). If you are passionate about participating in cutting-edge research publications, please do not hesitate to contact us about joining the board and contributing to the journal. This position is open to experts in all aspects of medicine and omics research. To apply for this position, recommend potential candidates or request further information, please contact (imo.office@accscience.sg) from the Innovative Medicines & Omics Editorial Office.   Welcome to join us! Innovative Medicines & Omics Editorial Office